News

The expiration of Viatris’s EpiPen patent in September 2025 will likely result in increased competition and lower costs in ...
NEW YORK, 8th August, 2025 (WAM) - United Nations Chief Antonio Guterres on Friday criticised Israel's plan to take control ...
(250808) -- CHENGDU, Aug. 8, 2025 (Xinhua) -- Tara Kriz of Germany competes during the women's wake surf skim qualification ...
Teva's Ajovy gains FDA approval for pediatric migraine prevention, offering hope for children aged 6-17 with this debilitating condition.
The drug price negotiation program has withstood another procedural effort in striking down one of the Inflation Reduction ...
The FDA expanded the indication for fremanezumab (Ajovy) injection for episodic migraine prevention to include children and ...
Drug regulatory agencies in Germany and Australia have added warnings that atomoxetine can trigger violent or suicidal thoughts—sparking urgent concern over its long‑term use in children and adults.
Maryville may soon enter into another six settlement lawsuits against nationwide Opioid drug manufacturers and distributors ...
Aurinia Pharmaceuticals Inc. achieved record Lupkynis sales of $66.6M in Q2 while managing cash flow. Click for insights on ...
In Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., Appeal No. 25-1228, The Federal Circuit found that claims reciting a ...
The demand for treatments targeting myeloproliferative disorders is rising sharply, propelled by several key factors that underscore the market's rob ...
RFK Jr. announced that the U.S. government’s emergency preparedness agency will no longer fund work on mRNA vaccines ...